+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodiagnostics Market Size, Share & Trends Analysis Report by Technology, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
Neurodiagnostics Market Size, Share & Trends Analysis Report by Technology, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
New

Neurodiagnostics Market Size, Share & Trends Analysis Report by Technology, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • February 2026
  • Region: Global
  • Grand View Research
  • ID: 5998769
REQUEST CUSTOMIZATION
Description Jump to:
The global neurodiagnostics market size was estimated at USD 19.01 billion in 2025 and is projected to reach USD 36.57 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, Parkinson’s disease, stroke, and depression, which are creating sustained demand for accurate and early diagnostic solutions.

In addition, the rising geriatric population is significantly contributing to market expansion, as elderly individuals are more susceptible to neurodegenerative and cerebrovascular diseases.

Technological advancements such as AI-integrated imaging, portable EEG devices, and high-resolution MRI and CT systems are improving diagnostic accuracy and workflow efficiency, further accelerating adoption across hospitals and diagnostic centers.

The advancements in neuroimaging technologies and the launch of new and innovative technologies by the key players in the market are further anticipated to drive market growth. For instance, in January 2025, Siemens Healthineers unveiled its latest diagnostic imaging innovations at the Asian Oceanian Congress of Radiology (AOCR) 2025 held in Chennai, strengthening its commitment to transforming healthcare through safe, accessible, flexible, and sustainable technologies that support improved patient care.

The showcase featured the Dry Cool technology-enabled, virtually helium-free 1.5T MAGNETOM Flow MRI, the Dual Source CT scanner SOMATOM Pro. Pulse, the locally manufactured Digital X-ray system MULTIX Impact E, and AI-powered ultrasound systems ACUSON Maple and ACUSON Sequoia. These solutions are designed to enhance diagnostic accuracy, improve workflow efficiency, and expand access to high-quality imaging, particularly across diverse healthcare settings.

Depression drives growth in the neurodiagnostic industry. The rising global burden of depressive disorders is increasing demand for objective brain-based evaluation tools such as MRI, PET, and EEG to better understand disease mechanisms, support research, and guide treatment selection. Depression is a significant mental health disorder worldwide and a leading cause of disability, creating sustained clinical and research demand for advanced neurological assessment technologies. Neuroimaging and neurophysiological techniques are used to study brain circuit changes, identify biomarkers, and support the development of personalized therapies, which directly expands the use of neurodiagnostic equipment and services.

Global Neurodiagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global neurodiagnostics market report based on technology, end use, and region:

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Neuroimaging Technologies
  • In Vitro Diagnostics
  • Neuroinformatics

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising prevalence of neurological disorders
3.3.1.2. Technological advancements
3.3.1.3. Government and private sector funding
3.3.2. Market Restraints Analysis
3.3.2.1. High cost of equipment and procedures
3.3.2.2. Limited reimbursement in emerging economies
3.3.3. Market Opportunity Analysis
3.3.3.1. Emergence of portable and point-of-care neurodiagnostic devices
3.3.3.2. Rising adoption in emerging markets
3.3.4. Market Challenge Analysis
3.3.4.1. Data privacy and integration issues
3.4. Neurodiagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neurodiagnostics Market: Technology Movement Analysis, USD Million, 2025 & 2033
4.3. Neuroimaging Technologies
4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Computed Tomography (CT)
4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Magnetic Resonance Imaging (MRI)
4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.4. Nuclear Medicine Imaging (PET, SPECT)
4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.5. Near infrared spectroscopic imaging (NIRS)
4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.6. Electro-encephalography (EEG)
4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.7. Magneto-encephalography (MEG)
4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.8. Voxel based morphometry (VBM)
4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4. In Vitro Diagnostics
4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Neuroinformatics
4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Neurodiagnostics Market: End Use Movement Analysis, USD Million, 2025 & 2033
5.3. Hospitals and Clinics
5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Diagnostic Laboratories
5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Imaging Centers
5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis, by Technology and by End Use
6.1. Neurodiagnostics Market Share, By Region, 2025 & 2033, USD Million
6.2. North America
6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3. Europe
6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.2. UK
6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.4. France
6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. China
6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. India
6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Latin America
6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Share Analysis, 2025
7.4. Company Profiles
7.4.1. Canon Medical Systems Corporation
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Siemens Healthineers AG
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Koninklijke Philips N.V.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Thermo Fisher Scientific, Inc.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. FUJIFILM Corporation
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Natus Medical Incorporated (ARCHIMED)
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Lifelines Neuro (SIDIS)
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Advanced Brain Monitoring, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. NIHON KOHDEN CORPORATION.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. F. Hoffmann-La Roche Ltd
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. GE HealthCare.
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. Mitsar Co. LTD.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives
7.4.13. Deymed Diagnostic
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/ Strategic Initiatives
7.4.14. Neurosoft
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/ Strategic Initiatives
7.4.15. Cadwell Industries
7.4.15.1. Participant’s Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/ Strategic Initiatives
7.4.16. Compumedics Limited
7.4.16.1. Participant’s Overview
7.4.16.2. Financial Performance
7.4.16.3. Product Benchmarking
7.4.16.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America Neurodiagnostics Market, By Region, 2021-2033 (USD Billion)
Table 3 North America Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 4 North America Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 5 U.S. Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 6 U.S. Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 7 Canada Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 8 Canada Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 9 Mexico Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 10 Mexico Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 11 Europe Neurodiagnostics Market, By Region, 2021-2033 (USD Billion)
Table 12 Europe Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 13 Europe Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 14 Germany Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 15 Germany Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 16 UK Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 17 UK Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 18 France Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 19 France Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 20 Italy Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 21 Italy Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 22 Spain Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 23 Spain Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 24 Denmark Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 25 Denmark Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 26 Sweden Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 27 Sweden Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 28 Norway Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 29 Norway Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 30 Asia Pacific Neurodiagnostics Market, By Region, 2021-2033 (USD Billion)
Table 31 Asia Pacific Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 32 Asia Pacific Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 33 China Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 34 China Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 35 Japan Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 36 Japan Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 37 India Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 38 India Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 39 South Korea Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 40 South Korea Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 41 Australia Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 42 Australia Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 43 Thailand Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 44 Thailand Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 45 Latin America Neurodiagnostics Market, By Region, 2021-2033 (USD Billion)
Table 46 Latin America Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 47 Latin America Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 48 Brazil Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 49 Brazil Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 50 Argentina Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 51 Argentina Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 52 MEA Neurodiagnostics Market, By Region, 2021-2033 (USD Billion)
Table 53 MEA Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 54 MEA Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 55 South Africa Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 56 South Africa Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 57 Saudi Arabia Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 58 Saudi Arabia Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 59 UAE Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 60 UAE Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
Table 61 Kuwait Neurodiagnostics Market, By Technology, 2021-2033 (USD Billion)
Table 62 Kuwait Neurodiagnostics Market, By End Use, 2021-2033 (USD Billion)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-Chain-Based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Neurodiagnostics Market: Market Outlook
Figure 9 Neurodiagnostics Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/Ancillary Market Outlook
Figure 12 Penetration And Growth Prospect Mapping
Figure 13 Industry Value Chain Analysis
Figure 14 Neurodiagnostics Market Driver Impact
Figure 15 Neurodiagnostics Market Restraint Impact
Figure 16 Neurodiagnostics Market Strategic Initiatives Analysis
Figure 17 Neurodiagnostics Market: Technology Movement Analysis
Figure 18 Neurodiagnostics Market: Technology Outlook And Key Takeaways
Figure 19 Technology Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 20 Neuroimaging Technologies Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 21 Computed Tomography (CT) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 22 Magnetic Resonance Imaging (MRI) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 23 Nuclear Medicine Imaging (PET, SPECT) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 24 Near Infrared Spectroscopic Imaging (NIRS) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 25 Electro-Encephalography (EEG) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 26 Magneto-Encephalography (MEG) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 27 Voxel Based Morphometry (VBM) Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 28 In Vitro Diagnostics Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 29 Neuroinformatics Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 30 Neurodiagnostics Market: End Use Movement Analysis
Figure 31 Neurodiagnostics Market: End Use Outlook And Key Takeaways
Figure 32 Hospitals & Clinics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 33 Diagnostic Laboratories Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 34 Imaging Centers Market Estimates And Forecasts,2021-2033 (USD Billion)
Figure 35 Others Market Estimates And Forecasts,2021-2033 (USD Billion)
Figure 36 North America Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 37 U.S. Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 38 Canada Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 39 Mexico Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 40 Europe Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 41 UK Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 42 Germany Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 43 France Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 44 Italy Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 45 Spain Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 46 Denmark Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 47 Sweden Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 48 Norway Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 49 Asia Pacific Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 50 China Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 51 Japan Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 52 India Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 53 Thailand Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 54 South Korea Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 55 Australia Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 56 Latin America Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 57 Brazil Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 58 Argentina Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 59 Middle East And Africa Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 60 South Africa Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 61 Saudi Arabia Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 62 UAE Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 63 Kuwait Neurodiagnostics Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 64 Market Share of Key Market Players- Neurodiagnostics Market

Companies Mentioned

The leading players profiled in this Neurodiagnostics market report include:
  • Canon Medical Systems Corporation
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Thermo Fisher Scientific, Inc.
  • FUJIFILM Corporation
  • Natus Medical Incorporated (Natus)
  • Lifelines Neuro
  • Advanced Brain Monitoring, Inc.
  • NIHON KOHDEN CORPORATION.
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare.
  • Mitsar Co. LTD.
  • Compumedics Limited
  • Cadwell Industries
  • Neurosoft
  • Deymed Diagnostic

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 19.01 Billion
Forecasted Market Value ( USD ) by 2033 $ 36.57 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Neurodiagnostics Market Report 2026 - Product Image

Neurodiagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neurodiagnostics Market - Global Forecast 2026-2032 - Product Image

Neurodiagnostics Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Neurodiagnostics - Global Strategic Business Report - Product Image

Neurodiagnostics - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Neurodiagnostics Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Neurodiagnostic And Monitoring Devices Market in the US 2025-2029 - Product Image

Neurodiagnostic And Monitoring Devices Market in the US 2025-2029

  • Report
  • 202 Pages
  • United States
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.